These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28869474)

  • 1. Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
    Weissberger GH; Melrose RJ; Fanale CM; Veliz JV; Sultzer DL
    J Alzheimers Dis; 2017; 60(2):707-719. PubMed ID: 28869474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
    Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
    Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
    JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
    Yamaguchi S; Meguro K; Ishii H; Meguro M; Akanuma K
    J Clin Neurosci; 2009 Nov; 16(11):1430-4. PubMed ID: 19632119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative characteristics of neuropsychological and neurometabolic changes in patients with Alzheimer's disease and vascular cognitive impairment].
    Emelin AY; Odinak MM; Lobzin VY; Kolmakova KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4. Vyp. 2):17-24. PubMed ID: 38696147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET mapping the brain substrates of visuo-constructive processing in Alzheimer's disease.
    Förster S; Teipel S; Zach C; Rominger A; Cumming P; Fougere Cl; Yakushev I; Haslbeck M; Hampel H; Bartenstein P; Bürger K
    J Psychiatr Res; 2010 May; 44(7):462-9. PubMed ID: 19875130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease.
    Salmon E; Perani D; Herholz K; Marique P; Kalbe E; Holthoff V; Delbeuck X; Beuthien-Baumann B; Pelati O; Lespagnard S; Collette F; Garraux G
    Hum Brain Mapp; 2006 Jul; 27(7):588-97. PubMed ID: 16247783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
    Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S
    Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
    Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
    Frings L; Hellwig S; Spehl TS; Bormann T; Buchert R; Vach W; Minkova L; Heimbach B; Klöppel S; Meyer PT
    Brain; 2015 Oct; 138(Pt 10):3089-99. PubMed ID: 26280595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unawareness of memory deficit in amnestic MCI: FDG-PET findings.
    Nobili F; Mazzei D; Dessi B; Morbelli S; Brugnolo A; Barbieri P; Girtler N; Sambuceti G; Rodriguez G; Pagani M
    J Alzheimers Dis; 2010; 22(3):993-1003. PubMed ID: 20858977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.
    Förster S; Buschert VC; Teipel SJ; Friese U; Buchholz HG; Drzezga A; Hampel H; Bartenstein P; Buerger K
    J Alzheimers Dis; 2011; 26 Suppl 3():337-48. PubMed ID: 21971473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset epilepsy with cognitive symptoms: Comparison of cognitive and imaging profiles with probable Alzheimer's disease.
    Zhang X; Ahmed R; Thayer Z; Breen N; McMillan J; Fulham M; Nikpour A
    Epilepsy Behav; 2023 Sep; 146():109371. PubMed ID: 37556966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.